Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

OCUL | Ocular Therapeutix Inc

IndexRUT P/E- EPS (ttm)-1.17 Insider Own5.33% Shs Outstand77.20M Perf Week-3.92%
Market Cap253.25M Forward P/E- EPS next Y-0.91 Insider Trans0.13% Shs Float75.16M Perf Month-15.16%
Income-90.73M PEG- EPS next Q-0.29 Inst Own54.72% Short Float / Ratio5.47% / 5.11 Perf Quarter-32.98%
Sales54.60M P/S4.64 EPS this Y-25.82% Inst Trans-2.89% Short Interest4.11M Perf Half Y-35.16%
Book/sh0.04 P/B81.88 EPS next Y21.75% ROA-61.38% Target Price12.62 Perf Year-44.23%
Cash/sh0.84 P/C3.80 EPS next 5Y50.08% ROE-263.41% 52W Range2.57 - 7.96 Perf YTD13.52%
Dividend- P/FCF- EPS past 5Y15.93% ROI-141.63% 52W High-59.92% Beta1.25
Dividend %- Quick Ratio3.04 Sales past 5Y119.20% Gross Margin91.57% 52W Low24.12% ATR0.18
Employees274 Current Ratio3.11 Sales Q/Q23.81% Oper. Margin-153.89% RSI (14)27.84 Volatility4.01% 4.62%
OptionableYes Debt/Eq20.96 EPS Q/Q-7.20% Profit Margin-166.17% Rel Volume0.52 Prev Close3.19
ShortableYes LT Debt/Eq19.73 EarningsAug 07 AMC Payout- Avg Volume804.80K Price3.19
Recom1.38 SMA20-12.91% SMA50-21.40% SMA200-33.16% Volume419,702 Change0.00%
Date Action Analyst Rating Change Price Target Change
Apr-21-23Initiated Robert W. Baird Outperform $18
Aug-10-22Resumed Berenberg Buy $15
Aug-10-21Upgrade H.C. Wainwright Neutral → Buy $17
Dec-28-20Downgrade H.C. Wainwright Buy → Neutral
Dec-17-20Initiated Berenberg Buy $27
Nov-13-20Reiterated Raymond James Strong Buy $15 → $25
Aug-10-20Reiterated H.C. Wainwright Buy $10 → $13
Mar-03-20Upgrade Raymond James Outperform → Strong Buy
May-21-19Reiterated H.C. Wainwright Buy $12 → $9
May-21-19Downgrade Raymond James Strong Buy → Outperform $11 → $5
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
Aug-07-23 07:15PM
06:05PM Loading…
Jul-24-23 08:00AM
Jul-14-23 06:59AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jun-10-23 06:30PM
Jun-07-23 08:00AM
Jun-05-23 04:01PM
Jun-02-23 09:37AM
08:00AM Loading…
Jun-01-23 08:00AM
May-09-23 11:42AM
May-08-23 06:15PM
May-04-23 09:50AM
Apr-28-23 08:00AM
Apr-24-23 08:00AM
Apr-14-23 04:01PM
Apr-07-23 08:49AM
Mar-11-23 07:22AM
Mar-08-23 08:50AM
05:37AM Loading…
Mar-07-23 08:40AM
Mar-06-23 05:15PM
Feb-28-23 08:00AM
Feb-27-23 05:15PM
Feb-21-23 08:00AM
Feb-16-23 05:15PM
Feb-13-23 05:52AM
Feb-11-23 08:00AM
Jan-06-23 08:00AM
Dec-24-22 07:34AM
Nov-13-22 07:10AM
Nov-08-22 08:00AM
Nov-07-22 05:25PM
Oct-24-22 06:00AM
Oct-17-22 08:11AM
Sep-30-22 09:27AM
Sep-27-22 10:21AM
Sep-22-22 07:00AM
Sep-07-22 04:01PM
Aug-10-22 08:00AM
Aug-08-22 05:45PM
Jul-25-22 08:00AM
Jul-13-22 01:58PM
Jun-13-22 01:23PM
Jun-08-22 07:00AM
Jun-01-22 08:00AM
May-13-22 06:03AM
May-09-22 05:45PM
May-03-22 05:35PM
Apr-26-22 08:00AM
Apr-25-22 08:00AM
Apr-14-22 04:35PM
Apr-12-22 10:46PM
Mar-04-22 08:00AM
Mar-02-22 07:28AM
Feb-28-22 05:35PM
Feb-23-22 06:05PM
Feb-22-22 08:00AM
Feb-11-22 08:00AM
Jan-18-22 08:00AM
Jan-12-22 09:38AM
Jan-04-22 08:00AM
Dec-06-21 07:00AM
Nov-20-21 06:09AM
Nov-15-21 08:00AM
Nov-09-21 01:17PM
Nov-08-21 07:35PM
Nov-05-21 11:44AM
Nov-01-21 08:00AM
Oct-29-21 04:01PM
Oct-28-21 03:05PM
Oct-25-21 03:13PM
Oct-24-21 10:00AM
Oct-22-21 03:30PM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mattessich Antony C.President and CEOAug 30Buy3.816,50024,7656,500Sep 05 08:27 AM
Ozden Rabia GursesChief Medical OfficerJul 07Sale4.938324,102100,531Jul 11 08:00 PM
Mattessich Antony C.President and CEOFeb 06Sale4.2419,66983,397446,281Feb 08 07:29 PM
Notman DonaldChief Financial OfficerFeb 06Sale4.246,47627,458139,387Feb 08 07:32 PM
Ozden Rabia GursesChief Medical OfficerFeb 06Sale4.246,41627,204101,363Feb 08 07:33 PM
Strassburger Philip C.General CounselFeb 06Sale4.246,18126,207109,071Feb 08 07:31 PM
White Christopher GChief Business OfficerFeb 06Sale4.245,82924,71594,766Feb 08 07:38 PM
SUMMER ROAD LLC10% OwnerNov 07Buy3.507,32825,6486,122,089Nov 09 04:48 PM
SUMMER ROAD LLC10% OwnerOct 11Buy3.9010,00038,9936,114,761Oct 12 04:34 PM
SUMMER ROAD LLC10% OwnerOct 10Buy4.0010,00039,9826,104,761Oct 12 04:34 PM
SUMMER ROAD LLC10% OwnerSep 29Buy4.0418,80075,9886,094,761Sep 29 07:51 PM
SUMMER ROAD LLC10% OwnerSep 28Buy4.101,2004,9206,075,961Sep 29 07:51 PM
SUMMER ROAD LLC10% OwnerSep 27Buy4.68130,000608,3226,074,761Sep 29 07:51 PM